Anticorps Recombinant de lapin anti-CD64
CD64 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
souris
Applications
FC
Conjugaison
Non conjugué
CloneNo.
241809A6
N° de cat : 98218-1-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en cytométrie | cellules médullaires de souris, |
Dilution recommandée
| Application | Dilution |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
98218-1-RR cible CD64 dans les applications de FC et montre une réactivité avec des échantillons souris
| Réactivité | souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | Protéine recombinante |
| Nom complet | Fc receptor, IgG, high affinity I |
| Masse moléculaire calculée | 45 kDa |
| Numéro d’acquisition GenBank | NM_010186.5 |
| Symbole du gène | Fcgr1 |
| Identification du gène (NCBI) | 14129 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Protein A purfication |
| Tampon de stockage | PBS with 0.09% sodium azide |
| Conditions de stockage | Store at 2 - 8°C. Stable for one year after shipment. |
Informations générales
Fcγ receptor comprise a multigene family of integral membrane glycoproteins that exhibit complex activation or inhibitory effects on cell functions after aggregation by complexed immunoglobulin G (IgG) (PMID: 17005690 ). CD64, also known as FcγRIA, is a high-affinity receptor for the Fc region of IgG. It is expressed by monocytes/macrophages, activated neutrophils, dendritic cells, and early myeloid cells (PMID: 23293080; 19642859; 7680917). CD64 functions in both innate and adaptive immune responses.
Protocole
| Product Specific Protocols | |
|---|---|
| FC protocol for CD64 antibody 98218-1-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |

